References
1. Meng L, Wang Z, Reilly M, Zhang S, Liu X, Lin D, et al. Amniotic
immune biomarkers as risk factors in women with different symptoms of
threatened late miscarriage. Am J Reprod Immunol. 2020;83(5):e13232.
2. Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson MD,
Fisher J, et al. Miscarriage matters: the epidemiological, physical,
psychological, and economic costs of early pregnancy loss. Lancet.
2021;397(10285):1658-67.
3. McPherson E. Recurrence of stillbirth and second trimester pregnancy
loss. Am J Med Genet A. 2016;170a(5):1174-80.
4. Ekdahl L, Eoh KJ, Thumuluru KM, Butler-Manuel SA, Tae Kim Y,
Lönnerfors C, et al. A combination of second trimester oral
metronidazole and no sexual intercourse during second and third
trimester may reduce late miscarriage and premature delivery after
fertility sparing radical trachelectomy. Eur J Obstet Gynecol Reprod
Biol. 2021;265:90-5.
5. Bu Z, Hu L, Su Y, Guo Y, Zhai J, Sun YP. Factors related to early
spontaneous miscarriage during IVF/ICSI treatment: an analysis of 21,485
clinical pregnancies. Reprod Biomed Online. 2020;40(2):201-6.
6. Schieve LA, Tatham L, Peterson HB, Toner J, Jeng G. Spontaneous
abortion among pregnancies conceived using assisted reproductive
technology in the United States. Obstet Gynecol. 2003;101(5 Pt
1):959-67.
7. Hu L, Du J, Lv H, Zhao J, Chen M, Wang Y, et al. Influencing factors
of pregnancy loss and survival probability of clinical pregnancies
conceived through assisted reproductive technology. Reprod Biol
Endocrinol. 2018;16(1):74.
8. Coppens M, Folkeringa N, Teune MJ, Hamulyák K, van der Meer J, Prins
MH, et al. Outcome of the subsequent pregnancy after a first loss in
women with the factor V Leiden or prothrombin 20210A mutations. J Thromb
Haemost. 2007;5(7):1444-8.
9. Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent
pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98.
10. Kling C, Magez J, Hedderich J, von Otte S, Kabelitz D. Two-year
outcome after recurrent first trimester miscarriages: prognostic value
of the past obstetric history. Arch Gynecol Obstet. 2016;293(5):1113-23.
11. Zeng H, Liu N, Fan X, Cai M, Xie H. [Risk factors for early
miscarriage among intrauterine singleton pregnancies after treatment
with in vitro fertilization/intracytoplasmic sperm injection]. Zhong
Nan Da Xue Xue Bao Yi Xue Ban. 2016;41(8):815-20.
12. Edlow AG, Srinivas SK, Elovitz MA. Second-trimester loss and
subsequent pregnancy outcomes: What is the real risk? Am J Obstet
Gynecol. 2007;197(6):581.e1-6.
13. Egerup P, Kolte AM, Larsen EC, Krog M, Nielsen HS, Christiansen OB.
Recurrent pregnancy loss: what is the impact of consecutive versus
non-consecutive losses? Hum Reprod. 2016;31(11):2428-34.
14. Ni T, Wu Q, Zhu Y, Jiang W, Zhang Q, Li Y, et al. Comprehensive
analysis of the associations between previous pregnancy failures and
blastocyst aneuploidy as well as pregnancy outcomes after PGT-A. J
Assist Reprod Genet. 2020;37(3):579-88.
15. Kling C, Hedderich J, Kabelitz D. Fertility after recurrent
miscarriages: results of an observational cohort study. Arch Gynecol
Obstet. 2018;297(1):205-19.
16. Bender Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S,
Middeldorp S, et al. ESHRE guideline: recurrent pregnancy loss. Hum
Reprod Open. 2018;2018(2):hoy004.
17. Guo Z, Xu X, Zhang L, Zhang L, Yan L, Ma J. Endometrial thickness is
associated with incidence of small-for-gestational-age infants in fresh
in vitro fertilization-intracytoplasmic sperm injection and embryo
transfer cycles. Fertil Steril. 2020;113(4):745-52.
18. Puissant F, Van Rysselberge M, Barlow P, Deweze J, Leroy F. Embryo
scoring as a prognostic tool in IVF treatment. Hum Reprod.
1987;2(8):705-8.
19. Gardner DK, Schoolcraft WB. Culture and transfer of human
blastocysts. Curr Opin Obstet Gynecol. 1999;11(3):307-11.
20. Cai H, Mol BW, Gordts S, Wang H, Wang T, Li N, et al. Early and late
pregnancy loss in women with polycystic ovary syndrome undergoing
IVF/ICSI treatment: a retrospective cohort analysis of 21 820
pregnancies. Bjog. 2021;128(7):1160-9.
21. Joubert M, Sibiude J, Bounan S, Mandelbrot L. Mid-trimester
miscarriage and subsequent pregnancy outcomes: the role of cervical
insufficiency in a cohort of 175 cases. J Matern Fetal Neonatal Med.
2021:1-6.
22. Diamant H, Mastrolia SA, Weintraub AY, Sheizaf B, Zilberstein T,
Yohay D. Effectiveness and safety of late midtrimester cervical
cerclage. J Matern Fetal Neonatal Med. 2019;32(18):3007-11.
23. Wang SW, Ma LL, Huang S, Liang L, Zhang JR. Role of Cervical
Cerclage and Vaginal Progesterone in the Treatment of Cervical
Incompetence with/without Preterm Birth History. Chin Med J (Engl).
2016;129(22):2670-5.
24. Chen R, Huang X, Li B. Pregnancy outcomes and factors affecting the
clinical effects of cervical cerclage when used for different
indications: A retrospective study of 326 cases. Taiwan J Obstet
Gynecol. 2020;59(1):28-33.
25. Hirayama E, Ebina Y, Kato K, Akabane-Nakagawa K, Okuyama K. Cervical
polyps in early pregnancy are a risk factor for late abortion and
spontaneous preterm birth: A retrospective cohort study. Int J Gynaecol
Obstet. 2022;156(1):64-70.
26. Kutteh WH, Triplett DA. Thrombophilias and recurrent pregnancy loss.
Semin Reprod Med. 2006;24(1):54-66.
27. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal
loss: a meta-analysis. Lancet. 2003;361(9361):901-8.
28. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, et al.
Thrombophilia in pregnancy: a systematic review. Br J Haematol.
2006;132(2):171-96.
29. Simcox LE, Ormesher L, Tower C, Greer IA. Thrombophilia and
Pregnancy Complications. Int J Mol Sci. 2015;16(12):28418-28.
30. Cicinelli E, Matteo M, Tinelli R, Pinto V, Marinaccio M, Indraccolo
U, et al. Chronic endometritis due to common bacteria is prevalent in
women with recurrent miscarriage as confirmed by improved pregnancy
outcome after antibiotic treatment. Reprod Sci. 2014;21(5):640-7.
31. Sakamoto J, Michels C, Eisfelder B, Joshi N. Trauma in Pregnancy.
Emerg Med Clin North Am. 2019;37(2):317-38.
32. El-Kady D, Gilbert WM, Anderson J, Danielsen B, Towner D, Smith LH.
Trauma during pregnancy: an analysis of maternal and fetal outcomes in a
large population. Am J Obstet Gynecol. 2004;190(6):1661-8.
33. Liu S, Mo M, Xiao S, Li L, Hu X, Hong L, et al. Pregnancy Outcomes
of Women With Polycystic Ovary Syndrome for the First In Vitro
Fertilization Treatment: A Retrospective Cohort Study With 7678
Patients. Front Endocrinol (Lausanne). 2020;11:575337.
34. Song Y, Ye W, Ye H, Xie T, Shen W, Zhou L. Serum testosterone acts
as a prognostic indicator in polycystic ovary syndrome-associated kidney
injury. Physiol Rep. 2019;7(16):e14219.